Clinical trial
Study of Bexxar <Tositumomab> Combined With External Beam Radiation Therapy
NCT00490490 · Stanford University, Other · Terminated
Key facts
| NCT number | NCT00490490 |
|---|---|
| Title | Study of Bexxar <Tositumomab> Combined With External Beam Radiation Therapy |
| Official title | Study of Bexxar <Tositumomab> Combined With External Beam Radiation Therapy for Patients With Relapsed, Bulky Non-Hodgkin's Lymphoma |
| Lead sponsor | Stanford University, Other |
| Collaborators | GlaxoSmithKline Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lymphoma, Non-Hodgkin |
| Intervention type | Drug, Procedure |
| Interventions | Bexxar (tositumomab), External beam radiotherapy (XRT), Potassium Iodide (KI) |
| Enrollment | 8 |
| Start date | Jan 1, 2007 |
| Primary completion | Jun 1, 2011 |
| Completion | Jul 1, 2013 |
| First posted | Jun 22, 2007 |
| Last update posted | Mar 29, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: